BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CARD11, BIMP3, 84433, ENSG00000198286, CARMA1, MGC133069, Q9BXL7
45 results:

  • 1. card11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
    Decombis S; Bellanger C; Le Bris Y; Madiot C; Jardine J; Santos JC; Boulet D; Dousset C; Menard A; Kervoelen C; Douillard E; Moreau P; Minvielle S; Moreau-Aubry A; Tessoulin B; Roue G; Bidère N; Le Gouill S; Pellat-Deceunynck C; Chiron D
    Blood; 2023 Nov; 142(18):1543-1555. PubMed ID: 37562004
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in card11 and KMT2D.
    Fukatsu M; Hamazaki Y; Sato Y; Koyama D; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):472-476. PubMed ID: 37133636
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B Signaling.
    Sato T; Maeta T; Ito S
    Anticancer Res; 2023 May; 43(5):1901-1908. PubMed ID: 37097671
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
    Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
    Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
    Jiang VC; Liu Y; Lian J; Huang S; Jordan A; Cai Q; Lin R; Yan F; McIntosh J; Li Y; Che Y; Chen Z; Vargas J; Badillo M; Bigcal JN; Lee HH; Wang W; Yao Y; Nie L; Flowers CR; Wang M
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719376
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. card11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
    Kameda T; Shide K; Kamiunten A; Kogure Y; Morishita D; Koya J; Tahira Y; Akizuki K; Yokomizo-Nakano T; Kubota S; Marutsuka K; Sekine M; Hidaka T; Kubuki Y; Kitai Y; Matsuda T; Yoda A; Ohshima T; Sugiyama M; Sashida G; Kataoka K; Ogawa S; Shimoda K
    Commun Biol; 2022 Nov; 5(1):1309. PubMed ID: 36446869
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of the CBM complex in allergic inflammation and disease.
    DeVore SB; Khurana Hershey GK
    J Allergy Clin Immunol; 2022 Nov; 150(5):1011-1030. PubMed ID: 35981904
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
    Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
    Front Immunol; 2022; 13():922471. PubMed ID: 35734168
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Methods to Study card11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
    Gewies A; Graß C; Krappmann D
    Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. carma1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
    Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
    J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway.
    Smith CIE; Burger JA
    Front Immunol; 2021; 12():689472. PubMed ID: 34177947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. card11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
    Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
    Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
    [No Abstract]    [Full Text] [Related]  

  • 14. Mechanistic understanding of the combined immunodeficiency in complete human card11 deficiency.
    Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
    J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
    Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
    Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.
    Uchida Y; Yoshimitsu M; Hachiman M; Kusano S; Arima N; Shima K; Hayashida M; Kamada Y; Nakamura D; Arai A; Tanaka Y; Hara H; Ishitsuka K
    Eur J Haematol; 2021 Feb; 106(2):221-229. PubMed ID: 33098696
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.
    Kataoka K; Koya J
    J Clin Exp Hematop; 2020 Sep; 60(3):66-72. PubMed ID: 32779615
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MALT-1 as a novel therapeutic target for adult T-cell leukemia.
    Ishikawa C; Mori N
    Eur J Haematol; 2020 Oct; 105(4):460-467. PubMed ID: 32574386
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic leukemia].
    Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.